You searched for "outcome"
ENT & Audiology in this issue...The Outer Ear
Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Priya Carling, AuD,Director and Consultant Audiologist,Kent Hearing Ltd, UK. E: priya@Kenthearing.com The outer ear is, we think, the unsung hero...Sound Sensation music festival
Alex Griffiths-Brown heads to Austria to hear MED-EL showcasing music by and for hearing implant users.BIOHIT HealthCare and the British Laryngological Association agree to corporate partnership
BIOHIT HealthCare is pleased to announce its corporate partnership with the British Laryngological Association (BLA) for 2022-2023, which brings together two organisations with the mission to advance laryngology diagnostics.
Identifying congenital CMV: the screening debate
Congenital cytomegalovirus (cCMV) is a significant global public health burden and is the biggest non-genetic cause of childhood hearing loss, as well as being an important cause of neurodevelopmental delay. Despite a study concluding that there was not enough evidence...
Can we predict risk of adverse events preoperatively in patients undergoing head and neck cancer surgery?
Ed’s Choice reviews a paper aiming to create a reliable index to predict postoperative outcomes in head and neck cancer patients. This interesting study identifies variables that may assist in risk assessing prospective surgical candidates. There have been a few...
Is there increased cardiovascular risk with macrolide antibiotics?
This month’s Ed’s Choice delightfully reviews the potential cardiovascular consequences of long-term macrolide use in the treatment of chronic rhinosinusitis. This used to be one of my ‘go-to’ topics of conversation at home after a bad day at work, although...BIOHIT launches new quick test to help streamline gastroscopy referrals
BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.
